Parth Solanki, M.S.

Associate Scientist II, Cellular Analytical Development

Parth is Associate Scientist II of Cellular Analytical Development at Strand Therapeutics. In previous academic research, Parth was working on the project for evaluation of monoclonal antibody target prevalence amongst diverse Nontypeable Haemophilus influenzae (NTHi) clinical isolates at AZ. He received his M.S. in Pharmaceutical Science from University of Maryland, Baltimore.